Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Guidance on choosing a retirement age for target date funds, with considerations for work horizon, withdrawals, and risk tolerance.
26,658 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
As rates stay elevated amid market turbulence, three preferred stock ETFs are emerging as ballast for retirement port...
A growing wave of pension funds is diversifying into crypto through regulated vehicles, signaling a major shift in re...
A key Fed decision on March 18 could set the tone for inflation and, in turn, the Social Security COLA for 2027. Reti...
A sudden loss can upend more than just emotions. This article breaks down concrete financial steps you can take to pr...
Investors are weighing the fate of the retiring cruise ship dream as the cruise industry rebounds. The reality check:...
Visa is more than a brand name. This article explores whether could buying visa stock make sense for long-term wealth...
taylor swift just exposed a blind spot in AI law as a landmark trademark push targets voice and likeness. Investors s...
Visa extends its four-year partnership with Red Bull Racing, expanding branding and fan experiences amid lingering qu...
Insider moves often raise questions for investors. This piece breaks down what Arteris CEO's stock sale could mean, h...
A rare market surge has happened only a handful of times since World War II. This article explains what that could me...
Rising Treasury yields are lifting single premium immediate annuities, offering guaranteed lifetime income for retire...